Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)

The summary for the Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional): The purpose of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translational cancer research, and to promote their career development as cancer researchers.

Federal Grant Title:	Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-22-136
Type of Funding:	Grant
CFDA Numbers:	93.398
CFDA Descriptions:	Information not provided
Current Application Deadline:	June 17th, 2024
Original Application Deadline:	June 17th, 2024
Posted Date:	April 11th, 2022
Creation Date:	April 11th, 2022
Archive Date:	July 23rd, 2024
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	April 11th, 2022

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-22-136.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allo...; • NCI Pathway to Independence Award (K99/R00 Clinical Trial Required); • NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Researc...; • NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Researc...; • NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Car...; • NCI Transition Career Development Award to Promote Diversity; • Cancer Education (R25E) Grants Program; • Cancer Prevention, Control, Behavioral and Population Sciences Career Development Award
More Grants from the National Institutes of Health: • HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery R...; • Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabet...; • Metastasis Research Network (U54 Clinical Trial Not Allowed); • Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U0...; • Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with...